Replies to post #208746 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

FDA themselves says there is "Less regulatory red tape"

A small firm like AVXL would be swamped by the processing requirements of supporting what we now have in WIP in U.S.(# trials). It would not be a surprise to find that many/most BP will have staff dedicated to supporting one trial or project w/dedicated FDA interface. One quickly sees that small companies may get lost in the process support in U.S.. If ,"Less regulatory red tape" is code for a better use of time and resources then I agree.